Advertisement
ANIP vs RMTI
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANIP is a Hold and RMTI is a Hold.
ANIP in downward trend: price dove below 50-day moving average on October 30, 2026
ANIP moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend. In 36 of 49 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 73%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Moving Average Convergence Divergence Histogram (MACD) for ANIP turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 59 similar instances when the indicator turned negative. In 42 of the 59 cases the stock turned lower in the days that followed. This puts the odds of success at 71%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ANIP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.
The Aroon Indicator for ANIP entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Momentum Indicator moved above the 0 level on November 10, 2026. You may want to consider a long position or call options on ANIP as a result. In 69 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 77%.
Following a +5.70% 3-day Advance, the price is estimated to grow further. Considering data from situations where ANIP advanced for three days, in 213 of 300 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
ANIP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 45 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 48 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 68 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.593) is normal, around the industry mean (6.379). P/E Ratio (13.957) is within average values for comparable stocks, (0.548). Projected Growth (PEG Ratio) (1.856) is also within normal values, averaging (2.202). Dividend Yield (0.000) settles around the average of (0.062) among similar stocks. P/S Ratio (1.657) is also within normal values, averaging (183.387).
The Tickeron Price Growth Rating for this company is 71 (best 1 - 100 worst), indicating slightly worse than average price growth. ANIP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
RMTI in -5.43% downward trend, declining for three consecutive days on November 10, 2026
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where RMTI declined for three days, in 294 of 326 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 46 of 54 cases where RMTI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 85%.
RMTI moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for RMTI crossed bearishly below the 50-day moving average on October 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 79%.
RMTI broke above its upper Bollinger Band on November 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for RMTI entered a downward trend on November 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 03, 2026. You may want to consider a long position or call options on RMTI as a result. In 58 of 72 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 81%.
The Moving Average Convergence Divergence (MACD) for RMTI just turned positive on November 03, 2026. Looking at past instances where RMTI's MACD turned positive, the stock continued to rise in 31 of 42 cases over the following month. The odds of a continued upward trend are 74%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 20 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.888) is normal, around the industry mean (6.379). P/E Ratio (-5.856) is within average values for comparable stocks, (0.548). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.202). Dividend Yield (0.000) settles around the average of (0.062) among similar stocks. P/S Ratio (0.435) is also within normal values, averaging (183.387).
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating steady price growth. RMTI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 75 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RMTI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
ANIP | RMTI | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 60 | 62 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 68 Overvalued | 20 Undervalued | |
PROFIT vs RISK RATING 1..100 | 45 | 100 | |
SMR RATING 1..100 | 48 | 94 | |
PRICE GROWTH RATING 1..100 | 71 | 59 | |
P/E GROWTH RATING 1..100 | 96 | 75 | |
SEASONALITY SCORE 1..100 | 85 | 41 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
RMTI's Valuation (20) in the Medical Specialties industry is somewhat better than the same rating for ANIP (68) in the Pharmaceuticals Other industry. This means that RMTI’s stock grew somewhat faster than ANIP’s over the last 12 months.
ANIP's Profit vs Risk Rating (45) in the Pharmaceuticals Other industry is somewhat better than the same rating for RMTI (100) in the Medical Specialties industry. This means that ANIP’s stock grew somewhat faster than RMTI’s over the last 12 months.
ANIP's SMR Rating (48) in the Pharmaceuticals Other industry is somewhat better than the same rating for RMTI (94) in the Medical Specialties industry. This means that ANIP’s stock grew somewhat faster than RMTI’s over the last 12 months.
RMTI's Price Growth Rating (59) in the Medical Specialties industry is in the same range as ANIP (71) in the Pharmaceuticals Other industry. This means that RMTI’s stock grew similarly to ANIP’s over the last 12 months.
RMTI's P/E Growth Rating (75) in the Medical Specialties industry is in the same range as ANIP (96) in the Pharmaceuticals Other industry. This means that RMTI’s stock grew similarly to ANIP’s over the last 12 months.
| ANIP | RMTI | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 2 days ago 75% | 2 days ago 85% |
| Momentum ODDS (%) | 2 days ago 77% | 2 days ago 81% |
| MACD ODDS (%) | 2 days ago 71% | 2 days ago 74% |
| TrendWeek ODDS (%) | 2 days ago 68% | 2 days ago 90% |
| TrendMonth ODDS (%) | 2 days ago 69% | 2 days ago 87% |
| Advances ODDS (%) | 2 days ago 71% | N/A |
| Declines ODDS (%) | 6 days ago 70% | 2 days ago 90% |
| BollingerBands ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 71% | 2 days ago 88% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ANIP’s FA Score shows that 0 FA rating(s) are green while RMTI’s FA Score has 1 green FA rating(s).
- ANIP’s FA Score: 0 green, 5 red.
- RMTI’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ANIP’s TA Score shows that 4 TA indicator(s) are bullish while RMTI’s TA Score has 2 bullish TA indicator(s).
- ANIP’s TA Score: 4 bullish, 4 bearish.
- RMTI’s TA Score: 2 bullish, 6 bearish.
Price Growth
ANIP (@Pharmaceuticals: Generic) experienced а -1.43% price change this week, while RMTI (@Pharmaceuticals: Generic) price change was -9.64% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.20%. For the same industry, the average monthly price growth was -6.54%, and the average quarterly price growth was +10.31%.
Reported Earning Dates
ANIP is expected to report earnings on Feb 26, 2027.
RMTI is expected to report earnings on Nov 12, 2026.
Industries' Descriptions
@Pharmaceuticals: Generic (-0.20% weekly)A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
Advertisement
ANIP and
Correlation & Price change
A.I.dvisor indicates that over the last year, ANIP has been loosely correlated with AMRX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIP jumps, then AMRX could also see price increases.
| Ticker / NAME | Correlation To ANIP | 1D Price Change % | ||
|---|---|---|---|---|
| ANIP | 100% | +5.10% | ||
| AMRX - ANIP | 39% Loosely correlated | +0.47% | ||
| AMPH - ANIP | 33% Loosely correlated | -1.09% | ||
| PBH - ANIP | 32% Poorly correlated | +2.98% | ||
| SNDL - ANIP | 31% Poorly correlated | -0.71% | ||
| COLL - ANIP | 30% Poorly correlated | -0.97% | ||
More | ||||
RMTI and
Correlation & Price change
A.I.dvisor tells us that RMTI and SNDL have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RMTI and SNDL's prices will move in lockstep.
| Ticker / NAME | Correlation To RMTI | 1D Price Change % | ||
|---|---|---|---|---|
| RMTI | 100% | -2.79% | ||
| SNDL - RMTI | 29% Poorly correlated | -0.71% | ||
| ZSTK - RMTI | 24% Poorly correlated | -5.95% | ||
| AMLX - RMTI | 23% Poorly correlated | +2.32% | ||
| ACB - RMTI | 23% Poorly correlated | -0.97% | ||
| ANIP - RMTI | 22% Poorly correlated | +5.10% | ||
More | ||||